Try our Advanced Search for more refined results

Chancery Sends Innoviva Board Fight With Sarissa To Trial

By Matt Chiappardi (June 14, 2017, 9:00 PM EDT) -- A Delaware Chancery judge ruled Wednesday that the dispute over biotech licensing firm Innoviva Inc.'s board makeup and whether activist hedge fund Sarissa Capital Management LP can have two director seats should go to trial after finding that there were too many disputed facts in the case....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!